These results might partly explain why diabetes mellitus (DM) leads to poorer outcome in stroke patients (Lau et al., 2019), as an inadequate level of GLUT1 exacerbates BBB damage, and provide insights into the neuroprotection of stroke patients with DM. The gene discussed is SLC2A1; the disease is stroke disorder.